Style Editor Docs
     
  • RadioGel™
    • Precision Radionuclide Therapy (PRnT)
    • Research (White Papers)
    • US FDA IDE Application
      • US FDA IDE Pre-Submission Process
    • Human Clinical Trials
  • IsoPet®
    • Regional Clinics
      • IsoPet® Therapy Dog • Cat Application
      • IsoPet® Therapy Equine Application
    • IsoPet® Therapy Pets
    • Veterinarians
    • Animal Studies
      • Canine Studies
      • Feline Studies
    • Our IsoPet® Mission
  • About Us
    • Management & Consultants
    • Advisory Boards
    • Contact - RadioGel™ | IsoPet®
  • Blog
  • Vivos Inc.
    • Press Releases
    • Board of Directors
    • SEC Filings
    • Contact - Investor Relations
   Contact Us
  • RadioGel™
    • Precision Radionuclide Therapy (PRnT)
    • Research (White Papers)
    • US FDA IDE Application
      • US FDA IDE Pre-Submission Process
    • Human Clinical Trials
  • IsoPet®
    • Regional Clinics
      • IsoPet® Therapy Dog • Cat Application
      • IsoPet® Therapy Equine Application
    • IsoPet® Therapy Pets
    • Veterinarians
    • Animal Studies
      • Canine Studies
      • Feline Studies
    • Our IsoPet® Mission
  • About Us
    • Management & Consultants
    • Advisory Boards
    • Contact - RadioGel™ | IsoPet®
  • Blog
  • Vivos Inc.
    • Press Releases
    • Board of Directors
    • SEC Filings
    • Contact - Investor Relations

    Sitemap

    • RadioGel™
      • Precision Radionuclide Therapy (PRnT)
      • Research (White Papers)
        • US FDA IDE Pre-Submission Process
      • Human Clinical Trials
    • IsoPet®
      • Regional Clinics
        • IsoPet® Therapy Dog • Cat Application
        • IsoPet® Therapy Equine Application
      • IsoPet® Therapy Pets
      • Animal Studies
        • Canine Studies
        • Feline Studies
      • Our IsoPet® Mission
    • About Us
      • Management & Consultants
      • Advisory Boards
      • Contact - RadioGel™ | IsoPet®
    • Blog
    • Vivos Inc.
      • Press Releases
      • Board of Directors
      • SEC Filings
      • Contact - Investor Relations

    Blog

    • 02/28/2023 - Vivos February 2023 Update | IsoPet® - RadioGel™
    • 02/10/2023 - Supply Chain Management | IsoPet® - RadioGel™
    • 02/01/2023 - Vivos January Update
    • 01/26/2023 - Path to FDA IDE Submission
    • 01/10/2023 - Exubrion Therapeutics® and Vivos Inc collaborate on joint abstract
    • 01/03/2023 - Vivos December Update
    • 12/29/2022 - Dr. John E. Heidrich, PHD, VCM joins our Veterinary Medicine Advisory Board
    • 12/01/2022 - Vivos November Update
    • 11/01/2022 - Vivos October Update
    • 10/01/2022 - Vivos September Update
    • 09/01/2022 - US FDA IDE Pre-Submission Progress Update
    • 05/24/2022 - US FDA IDE Pre-Submission Meeting Summary

    Vivos, Inc.

    Precision Radionuclide Therapy (PRnT)

    OTCQB: RDGL

    contact: info@radiogel.com


    Home Page Cover Image: 

     

    Veterinarian Dr. Michelle Myer from Vista Veterinarian Hospital in Kennewick, WA.

     

    Seen here administering IsoPet® therapy to a feline suffering from a sarcoma.

    RadioGel™ is a hydrogel liquid containing tiny yttrium-90 (90Y)  phosphate particles that may be administered directly into a tumor. The hydrogel is an yttrium-90 carrier at room temperature that gels within the tumor interstitial spaces after injection to keep the radiation sources safely in place. The short-range beta radiation from yttrium-90 localizes the dose within the treatment area so that normal organs and tissues are not adversely affected.

    IsoPet® Therapy Application(s)


    Precision Radionuclide Therapy (PRnT)


    Vivos Inc.
     - (OTCQB: RDGL) Investor Relations 

    Contact

     

    Main colors
       bg-primary
       bg-primary-light
       bg-primary-dark
       bg-secondary
       bg-secondary-dark
    Template sections
       body
       top-header
       header
       content
    Footer Styles
       background
       text color
       link color
       horizontal line
    Buttons
       style 1
       style 2
       style 3
    Other elements
      social icons
      navigation color
      subnav background
    Mobile navigation
       background color
       navigation color
    Template configurations
    has-right-nav g-font
    navigation styles
    size-15 weight-400 snip-nav
    content styles
    form-white
    footer styles
    o-form color-white
    Typography
    Heading H1
    weight-600
    Heading H2
    weight-600
    Heading H3
    weight-600
    Buttons
    weight-600 is-uppercase
    Animations

    Note:
    All changes made here will be applied to your entire website.
    is-switcher admin-only

    RadioGel™ Logo

    Precision Radionuclide Therapy (PRnT)

    draggable-logo

    About | Privacy Policy | Cookie Policy | Sitemap
    © 2023 Vivos Inc. | RadioGel™ is a registered trademark | IsoPet® is a registered trademark
    Log out | Edit
    • Scroll to top